Nassar A H, Awwad J, Khalil A M, Abu-Musa A, Mehio G, Usta I M
Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.
BJOG. 2007 Oct;114(10):1215-21. doi: 10.1111/j.1471-0528.2007.01492.x.
To compare patient satisfaction with two routes of misoprostol for term labour induction.
Prospective randomised trial.
Tertiary care hospital.
A total of 170 women admitted at > or = 37 weeks of gestation for induction of labour.
Women were randomised to receive 50 micrograms of either sublingual or vaginal misoprostol.
Patient satisfaction with the route of administration.
Despite a similar proportion reporting the labour induction as more painful than expected in both groups, a significantly lower proportion mentioned that the pelvic examinations were very painful in the sublingual group (19.7 versus 36.1%, relative risk [RR] 0.5, 95% CI 0.3-0.9). Request for analgesia was similar in both groups. More women in the sublingual group thought that the labour experience was better than expected (RR 2.0, 95% CI 1.2-3.3), had a positive attitude towards induction in subsequent pregnancies (RR 1.6, 95% CI 1.1-2.3) and preferred the same route in subsequent pregnancies (RR 3.1, 95% CI 2.2-4.5). Mean number of misoprostol doses, oxytocin augmentation, tachysystole and hyperstimulation, induction to vaginal delivery interval, vaginal delivery after a single dose, vaginal birth within 12 and 24 hours, and caesarean delivery rates were similar in both groups.
Sublingual misoprostol (50 micrograms) is associated with a significantly higher patient satisfaction rate compared with a similar dose of vaginal misoprostol. Sublingual administration offers additional choice to women, in particular those wishing to avoid vaginal administration.
比较米索前列醇两种给药途径用于足月引产时患者的满意度。
前瞻性随机试验。
三级护理医院。
共170例妊娠≥37周入院引产的妇女。
将妇女随机分为接受50微克舌下含服或阴道用米索前列醇两组。
患者对给药途径的满意度。
尽管两组中报告引产比预期更疼痛的比例相似,但舌下含服组提及盆腔检查非常疼痛的比例显著更低(19.7%对36.1%,相对危险度[RR]0.5,95%可信区间0.3 - 0.9)。两组的镇痛需求相似。舌下含服组更多妇女认为引产经历比预期更好(RR 2.0,95%可信区间1.2 - 3.3),对后续妊娠引产持积极态度(RR 1.6,95%可信区间1.1 - 2.3),且在后续妊娠中更倾向于相同给药途径(RR 3.1,95%可信区间2.2 - 4.5)。两组米索前列醇平均剂量、缩宫素加强使用、宫缩过速和子宫过度刺激、引产至阴道分娩间隔时间、单剂量后阴道分娩、12小时和24小时内阴道分娩以及剖宫产率相似。
与相同剂量的阴道用米索前列醇相比,舌下含服米索前列醇(50微克)患者满意度显著更高。舌下含服给药为妇女提供了额外选择,尤其是那些希望避免阴道给药的妇女。